Indivior Plc (INVVY) 21.4200 $INVVY The Zacks A
Post# of 273331
Posted On: 09/15/2016 7:09:09 AM
Indivior Plc (INVVY) 21.4200 $INVVY
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
Zacks Equity Research - Zacks Investment Research - Wed Nov 25, 8:30AM CST
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
AIRM: 31.11 (-0.70), GILD: 77.62 (-0.44), MYL: 40.84 (-0.07)
5 Cheap Health Care Stocks that Promise Healthy Returns
Zacks Equity Research - Zacks Investment Research - Tue Nov 24, 10:47AM CST
Last week's market sluggishness has created an amazing opportunity for investors in the healthcare space.
AIRM: 31.11 (-0.70), GILD: 77.62 (-0.44), UNH: 133.69 (-0.26), MYL: 40.84 (-0.07)
Lannett Company (LCI) Looks Good: Stock Gains 12.8%
Zacks Equity Research - Zacks Investment Research - Fri Sep 04, 8:46AM CDT
Lannett Company (LCI) was a big mover last session, with shares rising nearly 13% on the day.
LCI: 31.81 (+0.66)
Heron Therapeutics (HRTX) Looks Good: Stock Rises 14.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 04, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising nearly 15% on the day.
HRTX: 19.63 (+0.35)
Strength Seen in ImmunoGen (IMGN): Stock Soars 71.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 02, 8:46AM CDT
ImmunoGen (IMGN) was a big mover last session, with shares surging almost 72% on the day.
IMGN: 2.87 (+0.11)
CTI BioPharma Corp. (CTIC) in Focus: Stock Rises 11.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 02, 8:32AM CDT
CTI BioPharma Corp. (CTIC) was a big mover last session, as the company saw its shares rise nearly 12% on the day.
CTIC: 0.37 (-0.01)
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 01, 7:44AM CDT
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge nearly 11%
LJPC: 22.23 (+1.14)
3 Drug Stocks Prescribed for Portfolio Growth - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed May 27, 8:54AM CDT
Stocks with Growth Style Scores of A or B when combined with Zacks Rank #1 or #2 offer the best investment opportunities in the growth investing space.
ACT: 298.98 (-2.94), VRX: 27.38 (-0.15), PFE: 33.94 (-0.10), ABBV: 63.34 (unch), ANAC: 99.06 (-0.14), HSP: 89.95 (-0.01)
Sage Therapeutics (SAGE) Looks Good: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 22, 8:25AM CDT
Sage Therapeutics (SAGE) was a big mover last session, with shares rising over 8% on the day.
SAGE: 41.59 (+0.51)
Genocea Biosciences (GNCA) Jumps: Stock Gains 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 21, 7:30AM CDT
Genocea Biosciences (GNCA) was a big mover last session with its shares rising nearly 9% on the day.
GNCA: 5.44 (+0.12)
Strength Seen in Ardelyx (ARDX): Stock Rises 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed May 20, 8:55AM CDT
Ardelyx (ARDX) was a big mover last session, with shares rising over 15% on the day.
ARDX: 10.85 (+0.38)
Flamel Technologies (FLML) in Focus: Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 11, 7:37AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise roughly 11% on the day.
FLML: 13.64 (+0.07)
INDIVIOR PLC Admission to the Official List and to Trading on the London Stock Exchange
PR Newswire Europe - Tue Dec 23, 2:00AM CST
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT A PROSPECTUS BUT AN ADVERTISEMENT AND INVESTORS SHOULD NOT ACQUIRE ANY ORDINARY SHARES IN INDIVIOR PLC EXCEPT ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS PUBLISHED BY INDIVIOR PLC ON 17 NOVEMBER 2014 AND ANY SUPPLEMENT OR AMENDMENT THERETO
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
Zacks Equity Research - Zacks Investment Research - Wed Nov 25, 8:30AM CST
The Zacks Analyst Blog Highlights: Gilead Sciences, Mylan, Indivior, OmniComm Systems and Air Methods
AIRM: 31.11 (-0.70), GILD: 77.62 (-0.44), MYL: 40.84 (-0.07)
5 Cheap Health Care Stocks that Promise Healthy Returns
Zacks Equity Research - Zacks Investment Research - Tue Nov 24, 10:47AM CST
Last week's market sluggishness has created an amazing opportunity for investors in the healthcare space.
AIRM: 31.11 (-0.70), GILD: 77.62 (-0.44), UNH: 133.69 (-0.26), MYL: 40.84 (-0.07)
Lannett Company (LCI) Looks Good: Stock Gains 12.8%
Zacks Equity Research - Zacks Investment Research - Fri Sep 04, 8:46AM CDT
Lannett Company (LCI) was a big mover last session, with shares rising nearly 13% on the day.
LCI: 31.81 (+0.66)
Heron Therapeutics (HRTX) Looks Good: Stock Rises 14.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Jun 04, 8:25AM CDT
Heron Therapeutics (HRTX) was a big mover last session, with shares rising nearly 15% on the day.
HRTX: 19.63 (+0.35)
Strength Seen in ImmunoGen (IMGN): Stock Soars 71.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 02, 8:46AM CDT
ImmunoGen (IMGN) was a big mover last session, with shares surging almost 72% on the day.
IMGN: 2.87 (+0.11)
CTI BioPharma Corp. (CTIC) in Focus: Stock Rises 11.9% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Tue Jun 02, 8:32AM CDT
CTI BioPharma Corp. (CTIC) was a big mover last session, as the company saw its shares rise nearly 12% on the day.
CTIC: 0.37 (-0.01)
La Jolla Pharmaceutical (LJPC) in Focus: Stock Surges 10.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon Jun 01, 7:44AM CDT
La Jolla Pharmaceutical Co. (LJPC) was a big mover last session, as the company saw its shares surge nearly 11%
LJPC: 22.23 (+1.14)
3 Drug Stocks Prescribed for Portfolio Growth - Analyst Blog
Arpita Dutt - Zacks Investment Research - Wed May 27, 8:54AM CDT
Stocks with Growth Style Scores of A or B when combined with Zacks Rank #1 or #2 offer the best investment opportunities in the growth investing space.
ACT: 298.98 (-2.94), VRX: 27.38 (-0.15), PFE: 33.94 (-0.10), ABBV: 63.34 (unch), ANAC: 99.06 (-0.14), HSP: 89.95 (-0.01)
Sage Therapeutics (SAGE) Looks Good: Stock Rises 8.4% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 22, 8:25AM CDT
Sage Therapeutics (SAGE) was a big mover last session, with shares rising over 8% on the day.
SAGE: 41.59 (+0.51)
Genocea Biosciences (GNCA) Jumps: Stock Gains 8.8% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu May 21, 7:30AM CDT
Genocea Biosciences (GNCA) was a big mover last session with its shares rising nearly 9% on the day.
GNCA: 5.44 (+0.12)
Strength Seen in Ardelyx (ARDX): Stock Rises 15.3% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Wed May 20, 8:55AM CDT
Ardelyx (ARDX) was a big mover last session, with shares rising over 15% on the day.
ARDX: 10.85 (+0.38)
Flamel Technologies (FLML) in Focus: Stock Rises 10.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Mon May 11, 7:37AM CDT
Flamel Technologies SA (FLML) was a big mover last session, as the company saw its shares rise roughly 11% on the day.
FLML: 13.64 (+0.07)
INDIVIOR PLC Admission to the Official List and to Trading on the London Stock Exchange
PR Newswire Europe - Tue Dec 23, 2:00AM CST
- NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION (IN WHOLE OR IN PART) IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION. THIS ANNOUNCEMENT IS NOT A PROSPECTUS BUT AN ADVERTISEMENT AND INVESTORS SHOULD NOT ACQUIRE ANY ORDINARY SHARES IN INDIVIOR PLC EXCEPT ON THE BASIS OF THE INFORMATION CONTAINED IN THE PROSPECTUS PUBLISHED BY INDIVIOR PLC ON 17 NOVEMBER 2014 AND ANY SUPPLEMENT OR AMENDMENT THERETO
(0)
(0)